|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 162.30 EUR | 0.00% |
|
+2.79% | +36.39% |
| 07-22 | Ipsen Closes Purchase of Potravitug Developer Memo Therapeutics | MT |
| 07-14 | Where would AI lead Pharma in the long run? |  |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 161.67 | -0.39% | 15 | ||||||
| 1,270.37 | +9.23% | 27 | ||||||
| 270.59 | +5.85% | 22 | ||||||
| 266.89 | +5.37% | 28 | ||||||
| 359.22 | +8.07% | 18 | ||||||
| 153.89 | -0.13% | 21 | ||||||
| 212.16 | +24.85% | 22 | ||||||
| 317.2 | -0.72% | 24 | ||||||
| 356.69 | -2.56% | 29 | ||||||
| 157.59 | +20.91% | 27 | ||||||
| 28.75 | +15.83% | 26 | ||||||
| 62.96 | +3.62% | 24 | ||||||
| 554.91 | +17.42% | 23 | ||||||
| 95.6 | +24.41% | 22 | ||||||
| 21.39 | +11.96% | 20 | ||||||
| 9,853.33 | +34.87% | 15 | ||||||
| 6,126.87 | +10.35% | 15 | ||||||
| 80.52 | +45.37% | 15 | ||||||
| 54.92 | +16.92% | 18 | ||||||
| Average | 1,073.97 | +13.22% | 22 | ||||||
| Weighted average by Cap. | 714.93 | +9.65% | 24 |
- Stock Market
- Stocks
- IPN Stock
- Sector Ipsen
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
